Short-term immunotherapy: A prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 1, 1997, Pages 23-29

  Zenner, Hans Peter ^a   Baumgarten, Claus ^b   Rasp, Gerd ^c   Fuchs, Thomas ^d   Kunkel, Gert ^b   Hauswald, Bettina ^e   Ring, Johannes ^f   Effendy, Isaak ^g   Behrendt, Wolfram ^h   Frosch, Peter J ⁱ   Przybilla, Bernhard ^c   Brunner, Franz X ^j   Merk, Hans F ^k   Kapp, Alexander ^l   Schnitker, Jörg ^m   Wolf, Hendrik ⁿ  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Asthma Poliklinik im Rudolf Virchow   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g PHILIPPS UNIVERSITY MARBURG   (Germany)

^h UNIVERSITY HOSPITAL LEIPZIG   (Germany)

ⁱ UNIVERSITY OF WITTEN HERDECKE   (Germany)

^j UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^k RWTH AACHEN UNIVERSITY   (Germany)

^l HANNOVER MEDICAL SCHOOL   (Germany)

^m Inst für Angewandte Statistik   (Germany)

ⁿ ALK SCHERAX Arzneimittel GmbH   (Germany)

more..

Author keywords

Allergic rhinitis; Grass pollen; Rye pollen; Short term immunotherapy; Skin prick test; Specific IgE; Specific IgG4; Specific immunotherapy

Indexed keywords

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; CEREAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN TEST; TREATMENT OUTCOME;

EID: 0030808143     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70190-8     Document Type: Article

References (24)

1. Brunet C, Bedard PM, Lavoie A, Jobin M, Hebert J. Allergic rhinitis to ragweed pollen. I. Reassessment of the effects of immunotherapy on cellular and humoral responses. J Allergy Clin Immunol 1992;89:87-94.
2. Fling JA, Ruff ME, Parker WA, Whisman BA, Martin ME, Moss RB, et al. Suppression of the late cutaneous response by immunotherapy. J Allergy Clin Immunol 1989;83:101-9.
3. Parker WA, Wishman BA, Apaliski SJ, Reid MJ. The relationships between late cutaneous responses and specific antibody responses with outcome of immunotherapy for seasonal allergic rhinitis. J Allergy Clin Immunol 1989;84:667-77.
4. Turkeltaub PC, Campbell G, Mosimann JE. Comparative safety and efficacy of short ragweed extracts differing in potency and composition in the treatment of fall hay fever. Use of allergenically bioequivalent doses by parallel line bioassay to evaluate comparative safety and efficacy. Allergy 1990;45:528-46.
5. Nüchel-Petersen B, Janniche H, Munch EP, Wihl JA, Böwadt H, Ipsen H, et al. Immunotherapy with partially purified and standardized tree pollen extracts. I. Clinical results from a three-year double-blind study of patients treated with pollen extracts either of birch or combinations of alder, birch and hazel. Allergy 1988;43:353-62.
6. Wahn U, Schweter C, Lind P, Løwenstein H. Prospective study on immunologic changes induced by two different Dermatophagoides pteronyssinus extracts prepared from whole mite culture and mite bodies. J Allergy Clin Immunol 1988;82:360-70.
7. Van Metre TE, Marsh DG, Adkinson NF, Kagey-Sobotka A, Khattignavong A, Norman PS, et al. Immunotherapy for cat asthma. J Allergy Clin Immunol 1988;82:1055-68.
8. Wihl JA, Ipsen H, Nüchel-Petersen B, Munch EP, Janniche H, Löwenstein H. Immunotherapy with partially purified and standardized tree pollen extracts. II. Results of skin prick tests and nasal provocation tests from a three-year double-blind study of patients treated with pollen extracts either of birch or combinations of alder, birch and hazel. Allergy 1988;43:363-9.
9. Österballe O. Immunotherapy with grass pollen major allergens: clinical results from a prospective 3-year double blind study. Allergy 1982;37:379-88.
10. Haugaard L, Dahl R, Jacobsen L. A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects. J Allergy Clin Immunol 1993;91:709-22.
11. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. Br Med J 1991;302:265-9.
12. Mailing HJ, Weeke B, editors. Immunotherapy [position paper]. EAACI Immunotherapy subcommittee. Allergy 1993;48:3-35
13. European Economic Community (EEC) Note for Guidance, Good Clinical Practice for Trials on Medicinal Products in the European Community. CPMP Working Party on Efficacy of Medicinal Products. Final Approval 11.7.1990, Date for Coming into Operation 1.7. 1991, Pharm Toxicol 1990;67:361-72.
14. World Medical Association. Declaration of Helsinki, Hongkong 1989.
15. Gjesing B, Jaeger L, Marsh DG, Lowenstein H. The international collaborative study establishing the first international standard for timothy (Phleum pratense) grass pollen allergenic extract. J Allergy Clin Immunol 1985;75:258-67.
16. Sundin B, Lilja G, Graff-Lonnevig V, Hedlin G, Heilborn H, Norrlind K, et al. Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double-blind study on patients with animal dander asthma. J Allergy Clin Immunol 1986;77:478-87.
17. Aas K, Backmann A, Belin L, Weeke B. Standardization of allergen extracts with appropriate methods. The combined use of skin prick testing and radio-allergosorbent tests. Allergy 1978;33:130-7.
18. O'Brien PC. Procedures for comparing samples with multiple endpoints. Biometrics 1984;40:1079-87.
19. Lehmacher W, Wassmer G, Reitmeir P. Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate. Biometrics 1991;47:511-21.
20. Hedlin G, Silber G, Naclerio R, Proud D, Lamas AM, Eggleston P, et al. Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis. Clin Exp Allergy 1990;20:491-500.
21. McHugh SM, Lavelle B, Kemeny DM, Patel S, Ewan PW. A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses. J Allergy Clin Immunol 1990;86:521-32.
22. Djurup R. The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy. Allergy 1985;40:469-86.
23. Nakagawa T. The role of IgG subclass antibodies in the clinical response to immunotherapy in allergic disease. Clin Exp Allergy 1991;21:289-96.
24. Birkner T, Rumpold H, Jarolin E, Ebner H, Breitenbach M, Skvaril F, et al. Evaluation of immunotherapy-induced changes in specific IgE, IgG and IgG subclasses in birch pollen allergic patients by means of immunoblotting: correlation with clinical response. Allergy 1990;45:418-26.